OTC Markets OTCQB - Delayed Quote USD
NervGen Pharma Corp. (NGENF)
2.5900
+0.0100
+(0.39%)
At close: May 14 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 15.91M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Adams (William James) Senior Officer of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 76,505 | Mar 28, 2024 |
| Ives (Glenn Antony) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 14,775 | Mar 28, 2024 |
| Kaye (Randall E) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 17,360 | Mar 28, 2024 |
| Kelly (Michael) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 249,909 | Mar 28, 2024 |
| Mckerracher (Krista L) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 9,995 | Mar 28, 2024 |
| PFP Biosciences Holdings LLC 10% Security Holder of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 4,998,202 | Mar 28, 2024 |
| Punnett, Harold 10% Security Holder of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 44,323 | Mar 28, 2024 |
| Radvak (William Joseph) Director of Issuer | Acquisition or disposition carried out privately at price 1.74 per share. | Direct | 34,720 | Mar 28, 2024 |
| Ruffolo (John) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 73,872 | Mar 28, 2024 |
Related Tickers
MDNAF Medicenna Therapeutics Corp.
0.7490
-0.13%
ACXP Acurx Pharmaceuticals, Inc.
0.3676
-3.24%
ONWRF Onward Medical N.V.
4.8250
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0650
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
3.9399
+1.81%
RZLT Rezolute, Inc.
3.4900
-4.90%
ALDX Aldeyra Therapeutics, Inc.
2.1700
+4.33%
4KB.SG Krystal Biotech, Inc.
115.75
-1.28%
CAPR Capricor Therapeutics, Inc.
7.67
+5.07%
MSCLF Satellos Bioscience Inc.
0.4680
0.00%